Official Journal of the European Union

C 56/11

Prior notification of a concentration


Candidate case for simplified procedure

(Text with EEA relevance)

2011/C 56/07


On 14 February 2011, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the venture capital mutual fund AXA LBO Fund IV, which is managed by the company AXA Investment Managers Private Equity Europe SA (‘AXA IMPEE’, France), a member of the AXA group (France), acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of the NOVACAP group (‘NOVACAP’, France) by way of purchase of shares.


The business activities of the undertakings concerned are:

for the undertaking AXA IMPEE: investment fund,

for the undertaking NOVACAP: manufacturing and sale of chemicals for industry.


On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.


The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6130 — AXA IMPEE/NOVACAP, to the following address:

European Commission

Directorate-General for Competition

Merger Registry


1049 Bruxelles/Brussel


(1)  OJ L 24, 29.1.2004, p. 1 (the ‘EC Merger Regulation’).

(2)  OJ C 56, 5.3.2005, p. 32 (‘Notice on a simplified procedure’).